Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Michael Brody who wrote (858)	5/23/1999 10:08:00 AM
From: chirodoc	Read Replies (1) \| Respond to of 2344

the yahoo board is loaded with idiots--i just ran away.eom curtis

To: Michael Brody who wrote (858)	5/23/1999 10:38:00 AM
From: John Curtis	Read Replies (1) \| Respond to of 2344

Michael: Let's think about this for a second. BIOM in some sort of marketing deal........with WALMART?!? LOL! Does this mean they're gonna have their own shelf in the pharmaceutical section? HEH! Seriously though, me thinks that threadster jests. Still, thanks for the chuckle! Regards! John~

To: Michael Brody who wrote (858)	5/23/1999 12:00:00 PM
From: Angelo	Read Replies (1) \| Respond to of 2344

Michael, I think Biomira is one of the best investment you can make. All you can loose is $4000 U.S. but if they will get the approval (which I strongly believe they will)your $4000 U.S. dollars will become $100.000 in the next three years after the aproval.Some people on this thread might say I'm dreaming, that is not true.I will back up my words,take a look at Biochem Pharmaceutical,find out how many time they split after receiving approval on their a.i.d.s. drug, which by the way it was not a cancer vaccine.If Biochem pharma wouldn't split their share price I believe would be over $200 Canadian.A cancer vaccine if approved is a block buster drug. Naturally this is my opinion, (if you go in my personal profile you will find Biomira mentioned quite often)other people opinion might be different.Regarding F.D.A. approval for phase III testing, that approval, I believe has already been received,but it is possible that biomira might receive an early approval depending on the outcome of their testing in about six months.There is going to an investor teleconference,and in that occasion the stock price might go and will probally go up depending of what they have to say. Angelo